Drugs / IKDC-like cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02661685 | May 2016 → Oct 2019 | metastatic neoplasm | National Defense Medical Center, Taiwan | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | IKDC-like cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02661685 ↗ |
| Action | Deplete | “which can lyse tumor cells” NCT02661685 ↗ |
| Modality | Cell therapy | “autologous IKDC-like cell therapy” NCT02661685 ↗ |